The Significance of Atherogenic Indices in Patients on Hemodialysis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Nephrology

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000013566PMID 10773610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations.

  2008cited by this paper
• Relationship between parameters of the urea kinetic model and serum amino acid levels in patients on hemodialysis

  1999cited by this paper
• Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis.

  1998cited by this paper
• Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?

  1998cited by this paper
• Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage.

  1998cited by this paper
• Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

  1998cited by this paper
• Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.

  1998cited by this paper
• Evaluation of ankle-arm blood pressure index (AABI) as a marker of arteriosclerosis in hemodialysis patients

  1997cited by this paper
• Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis.

  1997cited by this paper
• Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

  1997cited by this paper
• Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

  1997cited by this paper
• Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.

  1997cited by this paper
• Cardiac troponin T composition in normal and regenerating human skeletal muscle.

  1997cited by this paper
• Adverse effects of hyperhomocysteinemia and their management by folic acid.

  1997cited by this paper
• Hyperhomocysteinemia in patients on dialysis, as determined by the methionine loading test

  1997cited by this paper
• Lipoprotein(a) in renal disease.

  1996cited by this paper
• Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.

  1996cited by this paper
• Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

  1996cited by this paper
• [Relationship between the stage of diabetic nephropathy and serum lipoprotein (a) concentrations--influence of hypoproteinemia].

  1996cited by this paper
• Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

  1996cited by this paper
• Myocardial troponin T levels in patients with diabetic nephropathy.

  1996cited by this paper
• Homocysteinemia and vascular disease in end-stage renal disease.

  1996cited by this paper
• Lipoprotein(a) in chronic renal disease.

  1996cited by this paper
• Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.

  1996cited by this paper
• Folic acid treatment of hyperhomocysteinemia in dialysis patients.

  1996cited by this paper
• Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure.

  1996cited by this paper
• Are the increased Lp(a) levels in hemodialysis patients related to glucose intolerance and hemodialysis duration?

  1996cited by this paper
• Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.

  1995cited by this paper
• Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.

  1995cited by this paper
• A comparative study of myocardial troponin T levels in patients undergoing hemodialysis.

  1995cited by this paper
• Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue.

  1995cited by this paper
• Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients.

  1995cited by this paper
• Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome.

  1995cited by this paper
• Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.

  1994cited by this paper
• Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations.

  1994cited by this paper
• Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis.

  1994cited by this paper
• Serum Lipoprotein (a) and Coronary Artery Disease in Uremic Patients on Chronic Hemodialysis

  1994cited by this paper
• Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.

  1993cited by this paper
• Decreased ankle/arm blood pressure index and mortality in elderly women.

  1993cited by this paper
• Serum lipoprotein (a) levels in maintenance hemodialysis patients.

  1993cited by this paper
• Plasma homocysteine in renal failure.

  1993cited by this paper
• Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

  1993cited by this paper
• Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.

  1993cited by this paper
• Serum cardiac troponin T in polymyositis/dermatomyositis.

  1992cited by this paper
• Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients

  1992cited by this paper
• Development and in vitro characterization of a new immunoassay of cardiac troponin T.

  1992cited by this paper
• Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle.

  1990cited by this paper
• Second receptor verified?

  1989cited by this paper
• Lipoprotein-remnant receptors: second receptor verified?

  1989cited by this paper
• Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood.

  1988cited by this paper
• Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.

  1987cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Turnover of lipoprotein (a) in man.

  1980cited by this paper
• Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis.

  1980cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper

• Evaluation of vascular quality of life questionnaire in dialysis patients with peripheral arterial disease treated by low-density lipoprotein apheresis

  2016cites this paper
• Ankle-arm blood pressure monitoring does not correlate with serum lipoprotein a in renal transplant recipients.

  2008cites this paper
• Intima Media Thickness of Common Carotid Arteries is Associated with Traditional Risk Factors and Presence of Ischemic Heart Disease in Hemodialysis Patients

  2005cites this paper
• Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients.

  2005cites this paper
• K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

  2005cites this paper
• Significance of Acute versus Chronic Troponin T Elevation in Dialysis Patients

  2004cites this paper
• Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease

  2004cites this paper
• Diabetes Mellitus, Hyperhomocystinemia and Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study

  2004cites this paper
• KRONİK HEMODİYALİZ HASTALARINDA PRİMER RENAL HASTALIKLARIN PLAZMA HOMOSİSTEİN DÜZEYLERİNE ETKİLERİ EFFECTS OF PRIMARY RENAL DISEASE ON PLASMA HOMOCYSTEINE CONCENTRATION IN CHRONIC HEMODIALYSIS PATIENTS

  2003cites this paper
• Inflammation, Malnutrition and Atherosclerosis in End-Stage Renal Disease: A Global Perspective

  2002cites this paper